YOUR BUSINESS AUTHORITY
Springfield, MO
U.K. pharmaceutical group GSK has entered a deal to purchase U.S. oncology biotech firm Nuvalent.
The deal is valued at $10.6 billion.
Nuvalent shares surged 39% on the deal, according to CNBC.
Read more from CNBC.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.